Results 141 to 150 of about 3,546 (164)

Targeting inflammation in the treatment of type 2 diabetes: time to start

Nature Reviews Drug Discovery, 2014
Marc Y Donath
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Omid Veiseh, Benjamin C Tang, Kathryn A Whitehead   +2 more
exaly  

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Kfir Sharabi, Pere Puigserver
exaly  

Nephrogenic Diabetes Insipidus

BMJ, 1963
openaire   +2 more sources

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

Lancet, The, 2016
Cj Chen, Oscar H Franco
exaly  

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Lancet, The, 2019
Hertzel C Gerstein, Gilles R Dagenais, Jeffrey Probstfield   +2 more
exaly  

Nephrogenic Diabetes Insipidus

2013
openaire   +1 more source

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Lancet, The, 2010
Erik Ingelsson, Naveed Sattar
exaly  

Nephrogenic Diabetes Insipidus

2016
openaire   +1 more source

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Y Donath, Steven E Shoelson
exaly